Methylphenidate Hydrochloride
NDC 62037-734, Methylphenidate Hydrochloride, tablet, film coated, extended release, from Actavis Pharma, Inc..
- Product NDC
- 62037-734
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076772
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/62037-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYLPHENIDATE HYDROCHLORIDE27 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62037-734-01 | 62037073401 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62037-734-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/85ef422d-af27-4126-9841-6892af1871d6NADAC price for package 62037073401
GET /v1/drugs/nadac/62037073401
Use it
Look up 62037-734 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62037-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62037-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.